Earnings Scheduled For October 28, 2021
Companies Reporting Before The Bell
• LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million.
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength.
Baxter Reports CE Mark For NEPHROCLEAR CCL14 Test
Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making and patient-centered approaches
Aids hospitals in
Baxter To Present Critical Care Data At Annual European Society Of Intensive Care Medicines Congress Oct. 3-6, 2021
Data supports the need for personalized approaches to care for critically ill patients with acute kidney injury (AKI) or sepsis
Two Baxter-sponsored symposia feature expert perspectives on digital transformation in
Baxter’s Norepinephrine Wins FDA Nod For Low Blood Pressure
The FDA has approved Baxter International Inc's (NYSE: BAX) premix norepinephrine bitartrate in 5% dextrose injection.
Cowen & Co. Upgrades Baxter Intl to Outperform, Announces $98 Price Target
Cowen & Co. analyst Joshua Jennings upgrades Baxter Intl (NYSE:BAX) from Market Perform to Outperform and announces $98 price target.
Barclays Upgrades Baxter Intl to Overweight, Raises Price Target to $100
Barclays analyst Travis Steed upgrades Baxter Intl (NYSE:BAX) from Equal-Weight to Overweight and raises the price target from $93 to $100.
